Clinical Update 5/05/2020 CBD for Osteoarthritis Pain A recent study, conducted in dogs, showed promise for CBD in reducing pain and inflammation due to osteoarthritis (pain due to worn joints)
Common Topical Application Patterns Use case Facial anti-aging (community use) Concentration 1-2% Frequency Once or twice daily Cycle length 8-12 weeks Use case Scalp / hair-research interest Concentration 1-3% Frequency Daily Cycle length 12+ weeks ongoing Use case Compounded post-procedure Concentration 1-2% Frequency Per clinician guidance Cycle length Per clinician guidance Topical concentrations are typically expressed as percent weight
Water, Niacinamide, Helianthus Annuus (Sunflower) Seed Oil, Cetyl Alcohol, Glycerin, Propylene Glycol, Cetearyl Alcohol, Alpha-Arbutin, Sorbitol, Stearyl Alcohol, Phenoxyethanol, Stearic Acid, Allantoin, Titanium Dioxide, Triethanolamine, Xanthan Gum, Tocopheryl Acetate, BHT, Disodium EDTA, Ethylhexylglycerin, Dicetyl Phosphate, Ceteth-10 Phosphate, Fragrance, Butyrospermum Parkii (Shea) Butter, Ascorbyl Glucoside, Glutathione
Sebbene la somministrazione topica sia meno biodisponibile dell'iniezione sottocutanea per effetti sistemici, efficace per applicazioni cutanee locali e adatta agli utilizzatori che preferiscono evitare le iniezioni
SPECT (Single Photon Emission Computed Tomography): Visualizes areas of hypoperfusion (low blood flow) that correlate with specific cognitive deficits
